Ironwood Pharmaceuti (IRWD)

$3.14 -0.23 (-6.82%)
Market Cap 510.04M
Revenue (ttm) 351.41M
Net Income (ttm) 880,000.00
EPS (ttm) N/A
PE Ratio 12.96
Forward PE 13.76
Profit Margin 0.25%
Debt to Equity Ratio -1.25
Volume 2,717,900
Avg Vol 1,978,186
Day's Range N/A - N/A
Shares Out 162.43M
Stochastic %K 78%
Beta 0.37
Analysts Hold
Price Target $1.85

Company Profile

Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It markets linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional constipation under the LINZESS and CONSTELLA na...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 617 621 7722
Fax: 617 494 0480
Address:
100 Summer Street, Suite 2300, Boston, United States
juneleeyo
juneleeyo Nov. 16 at 9:03 PM
$IRWD RSI cooled off to neutral. Setting up for the next leg up to $4-5 range?
0 · Reply
Nibbler
Nibbler Nov. 16 at 8:20 PM
$IRWD They have a new job opening for a Director, i think? Not sure if this means much or not.
1 · Reply
juneleeyo
juneleeyo Nov. 15 at 11:56 PM
$IRWD is trying to go back to $10/s like before. Sarissa and Alex Denner won't settle anything below $10/s imho. Need one more news to gap up hard. 1. Apra P3 announcement after FDA mtg (hopefully short and sweet) 2. TAM is increased with increased Adult and new Pediatric indications 3. Strategic announcement (Suspect M&A likely) 4. Linzess sales & revenues are increasing.
1 · Reply
Bio_Invest101
Bio_Invest101 Nov. 15 at 11:21 PM
$IRWD Kind of weird that Armistice Capital has not reported its filing yet?
0 · Reply
ASKING7
ASKING7 Nov. 15 at 7:30 PM
$IRWD the Big Boys holding, the most interesting one is definitely our GOLDMAN SACHS. GS did unload quite a lot, open discussion here on why and what you think, my thought is might due to conflit of interest of a closing deal soon
0 · Reply
WiseSolution
WiseSolution Nov. 15 at 2:45 AM
$IRWD what a great week. Small pullback to be expected before the run to 52 week high. Have a nice weekend
0 · Reply
Bio_Invest101
Bio_Invest101 Nov. 15 at 12:46 AM
$IRWD Get to know the new boss at CDER. If you’re long at IRWD and care about the fate and future of Apra/SBS rare disease patients here’s the good read and I think Tom McCourt would like his chances better now to go back to CDER for his “ short and quicker confirmatory trial for Apra ” done in about 6-12 months https://x.com/therealdansfera/status/1989381080768823753?s=46&t=0dxFfv8Iw4yOBhPO0oZagA
0 · Reply
revuelto
revuelto Nov. 14 at 11:56 PM
$IRWD BoA absolutely nailed this, https://www.sec.gov/Archives/edgar/data/1446847/000007085825000452/xslSCHEDULE_13G_X01/primary_doc.xml tell me they aren’t working with better intel than the rest of us …as for us microscopic retail it’s simple….either follow the behemoths or stay on the sidelines or sell too early 😀
0 · Reply
mkmike396
mkmike396 Nov. 14 at 11:01 PM
$IRWD fair sell off. We need to see two good earnings to really firm up the story. I will take some profits. Enjoy life and lookforward to ten
0 · Reply
buymoremakemore
buymoremakemore Nov. 14 at 10:33 PM
$IRWD what I want to buy after this is going down so we got nothing but time, baby!
0 · Reply
Latest News on IRWD
Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Nov 10, 2025, 7:05 AM EST - 6 days ago

Ironwood Pharmaceuticals Reports Strong Third Quarter 2025 Results; Raises Full Year 2025 Financial Guidance

Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta

Oct 24, 2025, 8:10 AM EDT - 23 days ago

Ironwood Stair & Rail Inc. Recognised With 2025 Consumer Choice Award for Stairs and Railings in Southern Alberta

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

Aug 7, 2025, 7:05 AM EDT - 3 months ago

Ironwood Pharmaceuticals Reports Second Quarter 2025 Results; Maintains Full Year 2025 Financial Guidance

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

May 7, 2025, 7:05 AM EDT - 6 months ago

Ironwood Pharmaceuticals Reports First Quarter 2025 Results

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Apr 30, 2025, 4:25 PM EDT - 7 months ago

Ironwood Pharmaceuticals to Participate in The Citizens Life Sciences Conference

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Apr 25, 2025, 7:05 AM EDT - 7 months ago

Ironwood Pharmaceuticals Reiterates Full-Year 2025 LINZESS U.S. Net Sales Guidance and Raises Adjusted EBITDA Guidance

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Apr 22, 2025, 4:05 PM EDT - 7 months ago

Ironwood Pharmaceuticals to Present Real-World Data at Digestive Disease Week® 2025 on Adoption of New Diagnosis Codes Among Short Bowel Syndrome Patients Who Are Dependent on Parenteral Support

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Apr 14, 2025, 2:19 PM EDT - 7 months ago

Ironwood Pharmaceuticals Stock Plunges, FDA Wants Another Trial For Gastrointestinal Drug

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Apr 14, 2025, 7:00 AM EDT - 7 months ago

Ironwood Pharmaceuticals Provides Clinical and Regulatory Update on Apraglutide

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Apr 10, 2025, 10:49 AM EDT - 7 months ago

Ironwood Pharmaceuticals: Setting A Strong Foundation For A Return To Growth

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Mar 27, 2025, 4:05 PM EDT - 8 months ago

Ironwood Pharmaceuticals Announces Receipt of Nasdaq Non-Compliance Notification Regarding Late 2024 Form 10-K Filing

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Mar 25, 2025, 8:30 AM EDT - 8 months ago

Industry Veteran Launches Ironwood III With Substantial Equity Commitment From Kayne Anderson Energy Infrastructure Fund

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 11:21 AM EST - 9 months ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q4 2024 Earnings Call Transcript

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Feb 27, 2025, 7:00 AM EST - 9 months ago

Ironwood Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Results; Achieves 2024 Financial Guidance

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Feb 20, 2025, 4:00 PM EST - 9 months ago

Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2024 Investor Update Call

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Jan 29, 2025, 4:05 PM EST - 10 months ago

Ironwood Pharmaceuticals Initiates Apraglutide NDA Submission, Highlights Compelling New Data and Updates Corporate Structure to Position for the Future

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Jan 17, 2025, 8:07 AM EST - 10 months ago

Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Nov 26, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Piper Sandler 36th Annual Healthcare Conference

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Nov 13, 2024, 4:01 PM EST - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies London Healthcare Conference

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 10:34 PM EST - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q3 2024 Earnings Call Transcript

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Nov 7, 2024, 7:00 AM EST - 1 year ago

Ironwood Pharmaceuticals Reports Third Quarter 2024 Results

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Oct 28, 2024, 7:00 AM EDT - 1 year ago

Once-Weekly Apraglutide Showed Consistent Treatment Effect Across Baseline Demographics and Disease Characteristics in Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF), According to New STARS Phase III Data from Ironwood at ACG 2024

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Oct 24, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Third Quarter 2024 Investor Update Call

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Aug 29, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the 2024 Wells Fargo Healthcare Conference

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Aug 9, 2024, 12:10 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. (IRWD) Q2 2024 Earnings Call Transcript

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Aug 8, 2024, 7:00 AM EDT - 1 year ago

Ironwood Pharmaceuticals Reports Second Quarter 2024 Results

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

Jul 25, 2024, 4:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Host Second Quarter 2024 Investor Update Call

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

Jun 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Starts Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Begin Conversation

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

Jun 26, 2024, 3:30 PM EDT - 1 year ago

The Schall Law Firm Initiates Inquiry Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Incurred Losses To Initiate Dialogue

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

Jun 25, 2024, 2:45 PM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors Who Suffered Losses To Initiate Contact

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

Jun 24, 2024, 4:45 PM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Establish Communication

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

Jun 23, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Initiates Probe Into Allegations Against Ironwood Pharmaceuticals Inc And Urges Investors With Losses To Connect

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Jun 22, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Begins Investigation Into Claims Against Ironwood Pharmaceuticals Inc And Encourages Investors With Losses To Reach Out

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Jun 20, 2024, 1:00 PM EDT - 1 year ago

Ironwood Pharmaceuticals: Q3 Of 2024 Data Readout For PBC

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Jun 19, 2024, 4:20 PM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals Inc The Schall Law Firm Initiates Probe And Urges Investors With Losses To Make Contact

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 18, 2024, 4:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals Inc The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Jun 11, 2024, 7:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Reach Out

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Jun 9, 2024, 11:00 AM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Urges Investors With Losses To Contact Them

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Jun 8, 2024, 11:00 AM EDT - 1 year ago

Allegations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Probe And Invites Investors With Losses To Get In Touch

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Jun 7, 2024, 3:00 PM EDT - 1 year ago

Claims Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Begins Investigation And Encourages Investors With Losses To Contact Them

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Jun 6, 2024, 1:00 PM EDT - 1 year ago

Accusations Against Ironwood Pharmaceuticals, Inc.: The Schall Law Firm Initiates Investigation And Invites Investors With Losses To Reach Out

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

Jun 5, 2024, 1:30 PM EDT - 1 year ago

Ironwood Pharmaceuticals, Inc. Accusations: Schall Law Firm Announces Investigation and Calls for Investors with Losses to Connect

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

Jun 4, 2024, 3:00 PM EDT - 1 year ago

The Schall Law Firm Declares an Inquiry into Accusations Against Ironwood Pharmaceuticals, Inc. and Advocates for Investors with Losses to Reach Out

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Jun 2, 2024, 11:00 AM EDT - 1 year ago

ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

May 31, 2024, 6:15 PM EDT - 1 year ago

ONGOING INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against Ironwood Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

May 30, 2024, 4:01 PM EDT - 1 year ago

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

May 21, 2024, 6:00 AM EDT - 1 year ago

Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)

juneleeyo
juneleeyo Nov. 16 at 9:03 PM
$IRWD RSI cooled off to neutral. Setting up for the next leg up to $4-5 range?
0 · Reply
Nibbler
Nibbler Nov. 16 at 8:20 PM
$IRWD They have a new job opening for a Director, i think? Not sure if this means much or not.
1 · Reply
juneleeyo
juneleeyo Nov. 15 at 11:56 PM
$IRWD is trying to go back to $10/s like before. Sarissa and Alex Denner won't settle anything below $10/s imho. Need one more news to gap up hard. 1. Apra P3 announcement after FDA mtg (hopefully short and sweet) 2. TAM is increased with increased Adult and new Pediatric indications 3. Strategic announcement (Suspect M&A likely) 4. Linzess sales & revenues are increasing.
1 · Reply
Bio_Invest101
Bio_Invest101 Nov. 15 at 11:21 PM
$IRWD Kind of weird that Armistice Capital has not reported its filing yet?
0 · Reply
ASKING7
ASKING7 Nov. 15 at 7:30 PM
$IRWD the Big Boys holding, the most interesting one is definitely our GOLDMAN SACHS. GS did unload quite a lot, open discussion here on why and what you think, my thought is might due to conflit of interest of a closing deal soon
0 · Reply
WiseSolution
WiseSolution Nov. 15 at 2:45 AM
$IRWD what a great week. Small pullback to be expected before the run to 52 week high. Have a nice weekend
0 · Reply
Bio_Invest101
Bio_Invest101 Nov. 15 at 12:46 AM
$IRWD Get to know the new boss at CDER. If you’re long at IRWD and care about the fate and future of Apra/SBS rare disease patients here’s the good read and I think Tom McCourt would like his chances better now to go back to CDER for his “ short and quicker confirmatory trial for Apra ” done in about 6-12 months https://x.com/therealdansfera/status/1989381080768823753?s=46&t=0dxFfv8Iw4yOBhPO0oZagA
0 · Reply
revuelto
revuelto Nov. 14 at 11:56 PM
$IRWD BoA absolutely nailed this, https://www.sec.gov/Archives/edgar/data/1446847/000007085825000452/xslSCHEDULE_13G_X01/primary_doc.xml tell me they aren’t working with better intel than the rest of us …as for us microscopic retail it’s simple….either follow the behemoths or stay on the sidelines or sell too early 😀
0 · Reply
mkmike396
mkmike396 Nov. 14 at 11:01 PM
$IRWD fair sell off. We need to see two good earnings to really firm up the story. I will take some profits. Enjoy life and lookforward to ten
0 · Reply
buymoremakemore
buymoremakemore Nov. 14 at 10:33 PM
$IRWD what I want to buy after this is going down so we got nothing but time, baby!
0 · Reply
juneleeyo
juneleeyo Nov. 14 at 10:15 PM
$IRWD Added a lot more at $3.35 today. Let's go! 🙌🏾
1 · Reply
Itinerant
Itinerant Nov. 14 at 9:48 PM
$IRWD WTF is that at the close? I guess that someone at the negotiation table farted. They need to get this thing done within the next couple of weeks so that we can enjoy Christmas/New Year's.
1 · Reply
ASKING7
ASKING7 Nov. 14 at 9:30 PM
$IRWD if you understand the concept between volume & share price, you know what’s going on here on technical level. Next few weeks we will have more confirmation, tbh the more retail sell the better it is for the longs, time will tell who is right soon.
0 · Reply
VSTN
VSTN Nov. 14 at 9:05 PM
$IRWD So dumb…I hope the penny flippers/sellers have huge regrets when when the big picture surfaces. It is what it is…
0 · Reply
Bio_Invest101
Bio_Invest101 Nov. 14 at 8:33 PM
$IRWD Retaials long need to pay close attentions in a day like today. BoA bought close to 250% more shares in Q3. I purposely posted the whole long filing so you could read it yourself and understand the big funds were buying and holding. And today some MM decided to beat it down for what?? Stay focused and don’t let them steal your cheap shares!
0 · Reply
VSTN
VSTN Nov. 14 at 8:22 PM
$IRWD Fucking up my vibe today.
1 · Reply
Bio_Invest101
Bio_Invest101 Nov. 14 at 8:02 PM
$IRWD Wow !! Bank Of America Corp /de/ ownership in IRWD / Ironwood Pharmaceuticals, Inc. 2025-11-14 - Bank Of America Corp /de/ has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 11,986,267 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD). This represents 7.4 percent ownership of the company. Bank Of America Corp /de/ has a history of taking positions in derivatives of the underlying security (IRWD) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 0 of underlying shares valued at $0 USD .
1 · Reply
Bio_Invest101
Bio_Invest101 Nov. 14 at 7:24 PM
$IRWD Interesting thing is happening RN. https://d18rn0p25nwr6d.cloudfront.net/CIK-0001446847/6f46a44e-e0a9-49ab-9fbb-d0d087e880ea.pdf
2 · Reply
revuelto
revuelto Nov. 14 at 6:19 PM
$IRWD any dip here is an opportunity to add…comes down to what you want…instant mini gratification or delayed exaltation…and better yet, we all know that “delayed” isn’t really delayed anymore 😀
0 · Reply
Bio_Invest101
Bio_Invest101 Nov. 14 at 6:07 PM
$IRWD Our RSI at 79.85 is neutral on week and 78.98 daily SELL but STRONG BUY in moving average What’s the TA guy thinking of this? I won’t be surprised SP ends up green at 4 pm today since no shorts would not cover for this weekend. Possibly Monday could see fireworks https://www.tradingview.com/symbols/NASDAQ-IRWD/technicals/
0 · Reply
Bio_Invest101
Bio_Invest101 Nov. 14 at 5:09 PM
$IRWD Holding strong On November 14, 2025 - Kynam Capital Management, LP filed a 13F-HR form disclosing ownership of 5,466,825 shares of Ironwood Pharmaceuticals, Inc. (US:IRWD) valued at $7,161,541 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 5,466,825 shares of Ironwood Pharmaceuticals, Inc.. This represents a change in shares of 0.00% during the quarter.
0 · Reply
mikestrong
mikestrong Nov. 14 at 4:51 PM
$IRWD Simply
0 · Reply